Tiziana Life Sciences Ltd
TLSA
Price:
$1.1429
Market Cap:
$117.82M
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-Interleukin 6 receptor (IL...[Read more]
Industry
Biotechnology
IPO Date
2018-11-20
Stock Exchange
NASDAQ
Ticker
TLSA
The ROE as of September 2024 (TTM) for Tiziana Life Sciences Ltd (TLSA) is -129.11%
According to Tiziana Life Sciences Ltd’s latest financial reports and current stock price. The company's current ROE is -129.11%. This represents a change of 828.64% compared to the average of -13.90% of the last 4 quarters.
Tiziana Life Sciences Ltd (TLSA) Historical ROE (quarterly & annually)
How has TLSA ROE performed in the past?
The mean historical ROE of Tiziana Life Sciences Ltd over the last ten years is -158.22%. The current -129.11% ROE has changed -18.40% with respect to the historical average. Over the past ten years (40 quarters), TLSA's ROE was at its highest in in the June 2019 quarter at 125.71%. The ROE was at its lowest in in the December 2018 quarter at -532.62%.
Average
-158.22%
Median
-69.77%
Minimum
-1458.64%
Maximum
402.26%
Tiziana Life Sciences Ltd (TLSA) ROE by Quarter and Year
Discovering the peaks and valleys of Tiziana Life Sciences Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 114.28%
Maximum Annual ROE = 402.26%
Minimum Annual Increase = -462.61%
Minimum Annual ROE = -1458.64%
| Year | ROE | Change |
|---|---|---|
| 2023 | 0% | -100.00% |
| 2022 | -82.82% | 45.99% |
| 2021 | -56.73% | 27.43% |
| 2020 | -44.52% | -125.47% |
| 2019 | 174.78% | -111.98% |
| 2018 | -1458.64% | -462.61% |
| 2017 | 402.26% | -284.94% |
| 2016 | -217.50% | 114.28% |
| 2015 | -101.51% | -48.61% |
| 2014 | -197.52% | -201.90% |
Tiziana Life Sciences Ltd (TLSA) Average ROE
How has TLSA ROE performed in the past?
The current ROE of Tiziana Life Sciences Ltd (TLSA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-46.51%
5-year avg
-1.86%
10-year avg
-158.22%
Tiziana Life Sciences Ltd (TLSA) ROE vs. Peers
How is TLSA’s ROE compared to its peers?
Tiziana Life Sciences Ltd’s ROE is less than Clearmind Medicine Inc. (0%), greater than Hillstream BioPharma, Inc. (-180.94%), greater than Coeptis Therapeutics, Inc. (-47249.59%), greater than Magenta Therapeutics, Inc. (-308.83%), greater than Quoin Pharmaceuticals, Ltd. (-61.71%), greater than Affimed N.V. (-112.11%), greater than Leap Therapeutics, Inc. (-155.57%), greater than Adaptimmune Therapeutics plc (-98.01%), greater than Corvus Pharmaceuticals, Inc. (-117.47%), greater than Aptose Biosciences Inc. (-53.99%), greater than Bionomics Limited (-5693.38%), greater than Accustem Sciences Inc. (-150.24%), less than Comera Life Sciences Holdings, Inc. (63.71%), less than SciSparc Ltd. (1.54%), greater than Biohaven Pharmaceutical Holding Company Ltd. (-87.48%), greater than Immunome, Inc. (-212.83%), greater than Inhibrx, Inc. (-157.86%), less than AgeX Therapeutics, Inc. (1.62%), less than Icosavax, Inc. (172.71%), greater than null (-41.24%),
| Company | ROE | Market cap |
|---|---|---|
| 0% | $5.23M | |
| -180.94% | $4.17M | |
| -47249.59% | $7.45M | |
| -308.83% | $42.44M | |
| -61.71% | $2.24M | |
| -112.11% | $61.82M | |
| -155.57% | $109.43M | |
| -98.01% | $268.49M | |
| -117.47% | $356.55M | |
| -53.99% | $7.24M | |
| -5693.38% | $7.45M | |
| -150.24% | $4.88M | |
| 63.71% | $682.38K | |
| 1.54% | $682.90K | |
| -87.48% | $3.90B | |
| -212.83% | $976.18M | |
| -157.86% | $250.80M | |
| 1.62% | $27.76M | |
| 172.71% | $769.04M | |
| -41.24% | $0 |
Build a custom stock screener for Tiziana Life Sciences Ltd (TLSA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tiziana Life Sciences Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Tiziana Life Sciences Ltd (TLSA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Tiziana Life Sciences Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Tiziana Life Sciences Ltd's ROE?
How is the ROE calculated for Tiziana Life Sciences Ltd (TLSA)?
What is the highest ROE for Tiziana Life Sciences Ltd (TLSA)?
What is the 3-year average ROE for Tiziana Life Sciences Ltd (TLSA)?
What is the 5-year average ROE for Tiziana Life Sciences Ltd (TLSA)?
How does the current ROE for Tiziana Life Sciences Ltd (TLSA) compare to its historical average?